Table 2.
Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | |
Age at diagnosisa | 0.97 | 0.95–0.99 | 0.0161 | 0.99 | 0.97–1.01 | 0.2332 |
Race | ||||||
Non-white | 1.00 | 1.00 | ||||
White | 4.67 | 2.67–8.17 | <0.0001 | 5.88 | 3.39–10.19 | <0.0001 |
Educationb | ||||||
≤High school graduate | 1.00 | – | ||||
>High school graduate | 1.17 | 0.72–1.89 | 0.5352 | – | ||
Marital statusb | ||||||
Non-married/non-partnered | 1.00 | – | ||||
Married/partnered | 1.28 | 0.81–2.03 | 0.2875 | – | ||
Pathological stage | ||||||
DCIS | 1.00 | 1.00 | ||||
Stage I | 0.96 | 0.62–1.50 | 0.8567 | 1.07 | 0.66–1.72 | 0.7902 |
Stage IIA | 1.73 | 0.92–3.23 | 0.0909 | 1.24 | 0.60–2.57 | 0.5635 |
Type of surgeryb | ||||||
Mastectomy | 1.00 | – | ||||
Breast-conserving surgery | 0.86 | 0.54–1.38 | 0.5349 | – | ||
Received chemotherapy | 1.65 | 1.08–2.54 | 0.0213 | 1.52 | 0.94–2.43 | 0.0856 |
Received radiation therapy | 0.75 | 0.56–1.01 | 0.0554 | 0.72 | 0.54–0.96 | 0.0271 |
Received adjuvant hormone therapyb | 1.00 | 0.76–1.32 | 0.9827 | – | ||
Family history of breast cancerb | 1.03 | 0.66–1.62 | 0.8915 | – | ||
Time after definitive surgery (months)a,b | 1.00 | 0.99–1.01 | 0.5531 | – | ||
Surgical side effectsa | 1.21 | 0.96–1.52 | 0.1040 | 1.00 | 0.78–1.28 | 0.9923 |
Charlson comorbidity indexa,b | 0.99 | 0.83–1.17 | 0.8730 | – | ||
Social supporta | 0.55 | 0.44–0.70 | <0.0001 | 0.59 | 0.46–0.75 | <0.0001 |
State anxietya | 1.06 | 1.03–1.08 | <0.0001 | 1.04 | 1.02–1.07 | 0.0016 |
Elevated depressive symptoms | 1.82 | 1.22–2.71 | 0.0033 | 1.09 | 0.69–1.71 | 0.7106 |
Factors analyzed as continuous explanatory variables in which odds ratios correspond to a unit increase
Variable not included in the multivariate model, because not significantly associated with perceived risk of recurrence in univariate model